GlassScriptPhysician profile
Julia C Flowers
NPI 1669433140
$19,403.24
in general payments reported to CMS, 2019-2025
33 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $256 · 2021: $486 · 2022: $754 · 2023: $535 · 2024: $5,022 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $1,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,800.00 |
| Food and Beverage | $1,335.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $15,818.21 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $605.06 | 2019-2023 | |
| Pfizer INC. | $347.07 | 2019-2024 | |
| Exeltis, USA INC. | $344.05 | 2019-2025 | Slynd |
| Celularity INC. | $300.00 | 2019 | |
| Biogen, INC. | $174.01 | 2024-2025 | Zurzuvae, Vumerity |
| Mayne Pharma Commercial LLC | $165.82 | 2021-2025 | |
| Allergan, INC. | $161.86 | 2019-2020 | |
| Astellas Pharma US INC | $151.95 | 2022-2025 | Veozah, Myrbetriq |
| Organon LLC | $121.38 | 2022-2025 | Nexplanon, Jada System |
| Millicent US INC | $116.25 | 2020-2025 | Intrarosa, Femlyv |
| Minerva Surgical, INC | $99.61 | 2019-2024 | |
| Scynexis, INC. | $90.38 | 2022 | |
| Merck Sharp & Dohme LLC | $87.40 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $80.42 | 2023-2025 | Myfembree |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $77.83 | 2019-2021 | |
| Hologic Sales and Service, LLC | $71.90 | 2022-2025 | Fluent Fluid Management System, Acessa Provu System, Novasure |
| Myovant Sciences INC. | $66.46 | 2022 | |
| Agile Therapeutics, INC. | $65.43 | 2022-2024 | Twirla |
| Medtronic, INC. | $58.28 | 2022-2024 | Venaseal |
| Avion Pharmaceuticals | $57.17 | 2019-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $55.58 | 2019-2024 | |
| Convatec INC. | $42.44 | 2023-2024 | |
| Shield Therapeutics INC | $41.94 | 2023-2024 | Accrufer |
| Dilon Technologies, INC. | $36.97 | 2025 | Hemoblast Bellows |
| Therapeuticsmd, INC. | $34.08 | 2019 | |
| Coopersurgical, INC. | $31.31 | 2019-2022 | |
| Dexcom, INC. | $24.66 | 2025 | Dexcom G6 Transmitter |
| Organogenesis INC. | $19.86 | 2025 | Cygnus Matrix |
| Pacira Pharmaceuticals Incorporated | $18.69 | 2020 | |
| Duchesnay USA Incorporated | $15.85 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.31 | 2019 | |
| Channel Medsystems, INC. | $9.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Flowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.